191 related articles for article (PubMed ID: 25134759)
1. Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes.
Terasawa T; Aso Y; Omori K; Fukushima M; Momobayashi A; Inukai T
Transl Res; 2015 Feb; 165(2):336-45. PubMed ID: 25134759
[TBL] [Abstract][Full Text] [Related]
2. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
3. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages.
Kramer PR; Kramer SF; Guan G
Arthritis Rheum; 2004 Jun; 50(6):1967-75. PubMed ID: 15188374
[TBL] [Abstract][Full Text] [Related]
4. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients.
Siedlar M; Strach M; Bukowska-Strakova K; Lenart M; Szaflarska A; Węglarczyk K; Rutkowska M; Baj-Krzyworzeka M; Pituch-Noworolska A; Kowalczyk D; Grodzicki T; Ziegler-Heitbrock L; Zembala M
Clin Immunol; 2011 May; 139(2):122-32. PubMed ID: 21300572
[TBL] [Abstract][Full Text] [Related]
5. Increased Toll-like receptor-2 expression on nonclassic CD16+ monocytes from patients with inflammatory stage of Eales' disease.
Sen A; Chowdhury IH; Mukhopadhyay D; Paine SK; Mukherjee A; Mondal LK; Chatterjee M; Bhattacharya B
Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6940-8. PubMed ID: 21791592
[TBL] [Abstract][Full Text] [Related]
6. Xuemaitong granules attenuate carotid atherosclerosis by decreasing the expression of CD14+CD16+ monocytes, IL-6, TNF-α, and hsCRP.
Zhang Q; Qian G; Ding Z
Genet Mol Res; 2014 Sep; 13(3):7519-27. PubMed ID: 25222252
[TBL] [Abstract][Full Text] [Related]
7. Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.
Merino A; Alvarez-Lara MA; Ramirez R; Carracedo J; Martin-Malo A; Aljama P
Nephrol Dial Transplant; 2012 Jul; 27(7):2907-12. PubMed ID: 22247233
[TBL] [Abstract][Full Text] [Related]
8. Selective expansion of the CD14(+)/CD16(bright) subpopulation of circulating monocytes in patients with hemophagocytic syndrome.
Takeyama N; Yabuki T; Kumagai T; Takagi S; Takamoto S; Noguchi H
Ann Hematol; 2007 Nov; 86(11):787-92. PubMed ID: 17619880
[TBL] [Abstract][Full Text] [Related]
9. Specific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.
Takai C; Matsumoto I; Inoue A; Umeda N; Tanaka Y; Kurashima Y; Wada Y; Narita I; Sumida T
Clin Exp Immunol; 2015 Jun; 180(3):458-66. PubMed ID: 25683200
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol supplementation decreases blood glucose without changing the circulating CD14
Khodabandehloo H; Seyyedebrahimi S; Esfahani EN; Razi F; Meshkani R
Nutr Res; 2018 Jun; 54():40-51. PubMed ID: 29914666
[TBL] [Abstract][Full Text] [Related]
11. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
Burbano C; Vasquez G; Rojas M
Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection.
Castaño D; García LF; Rojas M
Tuberculosis (Edinb); 2011 Sep; 91(5):348-60. PubMed ID: 21621464
[TBL] [Abstract][Full Text] [Related]
14. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells.
Slusher AL; Zúñiga TM; Acevedo EO
Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629
[TBL] [Abstract][Full Text] [Related]
15. Bacterial DNA and endothelial damage in haemodialysis patients.
Merino A; Nogueras S; García-Maceira T; Rodríguez M; Martin-Malo A; Ramirez R; Carracedo J; Aljama P
Nephrol Dial Transplant; 2008 Nov; 23(11):3635-42. PubMed ID: 18511607
[TBL] [Abstract][Full Text] [Related]
16. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.
Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
Metabolism; 2010 Dec; 59(12):1775-83. PubMed ID: 20580035
[TBL] [Abstract][Full Text] [Related]
17. Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation.
Powell LA; Crowe P; Kankara C; McPeake J; McCance DR; Young IS; Trimble ER; McGinty A
Clin Sci (Lond); 2012 Aug; 123(3):135-46. PubMed ID: 22309242
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
19. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
20. CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis.
Poitou C; Dalmas E; Renovato M; Benhamo V; Hajduch F; Abdennour M; Kahn JF; Veyrie N; Rizkalla S; Fridman WH; Sautès-Fridman C; Clément K; Cremer I
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2322-30. PubMed ID: 21799175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
